These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35274356)

  • 21. Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial.
    McAuley SA; Trawley S; Vogrin S; Ward GM; Fourlanos S; Grills CA; Lee MH; Alipoor AM; O'Neal DN; O'Regan NA; Sundararajan V; Colman PG; MacIsaac RJ
    Diabetes Care; 2022 Feb; 45(2):381-390. PubMed ID: 34844995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experiences of children/young people and their parents, using insulin pump therapy for the management of type 1 diabetes: qualitative review.
    Alsaleh FM; Smith FJ; Taylor KM
    J Clin Pharm Ther; 2012 Apr; 37(2):140-7. PubMed ID: 21729118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Customization of home closed-loop insulin delivery in adult patients with type 1 diabetes, assisted with structured remote monitoring: the pilot WP7 Diabeloop study.
    Benhamou PY; Huneker E; Franc S; Doron M; Charpentier G;
    Acta Diabetol; 2018 Jun; 55(6):549-556. PubMed ID: 29520615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fear of hypoglycemia in children with type 1 diabetes and their parents: Effect of pump therapy and continuous glucose monitoring with option of low glucose suspend in the CGM TIME trial.
    Verbeeten KC; Perez Trejo ME; Tang K; Chan J; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Richardson C; Cooper T; Lawson ML;
    Pediatr Diabetes; 2021 Mar; 22(2):288-293. PubMed ID: 33179818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the Hybrid Closed-Loop System on Sleep and Quality of Life in Youth with Type 1 Diabetes and Their Parents.
    Cobry EC; Hamburger E; Jaser SS
    Diabetes Technol Ther; 2020 Nov; 22(11):794-800. PubMed ID: 32212971
    [No Abstract]   [Full Text] [Related]  

  • 26. Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6-12 years: a randomised, controlled, cross-over, non-inferiority trial.
    Kariyawasam D; Morin C; Casteels K; Le Tallec C; Sfez A; Godot C; Huneker E; Garrec N; Benhamou PY; Polak M; Charpentier G; Franc S; Beltrand J
    Lancet Digit Health; 2022 Mar; 4(3):e158-e168. PubMed ID: 35216750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Very Young Children: A Multicenter, 3-Week, Randomized Trial.
    Tauschmann M; Allen JM; Nagl K; Fritsch M; Yong J; Metcalfe E; Schaeffer D; Fichelle M; Schierloh U; Thiele AG; Abt D; Kojzar H; Mader JK; Slegtenhorst S; Barber N; Wilinska ME; Boughton C; Musolino G; Sibayan J; Cohen N; Kollman C; Hofer SE; Fröhlich-Reiterer E; Kapellen TM; Acerini CL; de Beaufort C; Campbell F; Rami-Merhar B; Hovorka R;
    Diabetes Care; 2019 Apr; 42(4):594-600. PubMed ID: 30692242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MD-Logic overnight type 1 diabetes control in home settings: A multicentre, multinational, single blind randomized trial.
    Nimri R; Bratina N; Kordonouri O; Avbelj Stefanija M; Fath M; Biester T; Muller I; Atlas E; Miller S; Fogel A; Phillip M; Danne T; Battelino T
    Diabetes Obes Metab; 2017 Apr; 19(4):553-561. PubMed ID: 27981804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved technology satisfaction and sleep quality with Medtronic MiniMed® Advanced Hybrid Closed-Loop delivery compared to predictive low glucose suspend in people with Type 1 Diabetes in a randomized crossover trial.
    Wheeler BJ; Collyns OJ; Meier RA; Betts ZL; Frampton C; Frewen CM; Galland B; Hewapathirana NM; Jones SD; Chan DSH; Roy A; Grosman B; Kurtz N; Shin J; Vigersky RA; de Bock MI
    Acta Diabetol; 2022 Jan; 59(1):31-37. PubMed ID: 34453208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experiences in Sensor-Augmented Pump Therapy in Families with two Children with Type 1 diabetes: A Qualitative Study.
    Bomba F; Müller-Godeffroy E; von Sengbusch S
    Exp Clin Endocrinol Diabetes; 2018 Mar; 126(3):162-167. PubMed ID: 28750428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acceptability and utility of the mySentry remote glucose monitoring system.
    Kaiserman K; Buckingham BA; Prakasam G; Gunville F; Slover RH; Wang Y; Nguyen X; Welsh JB
    J Diabetes Sci Technol; 2013 Mar; 7(2):356-61. PubMed ID: 23566993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial.
    Bergenstal RM; Nimri R; Beck RW; Criego A; Laffel L; Schatz D; Battelino T; Danne T; Weinzimer SA; Sibayan J; Johnson ML; Bailey RJ; Calhoun P; Carlson A; Isganaitis E; Bello R; Albanese-O'Neill A; Dovc K; Biester T; Weyman K; Hood K; Phillip M;
    Lancet; 2021 Jan; 397(10270):208-219. PubMed ID: 33453783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Living with sensor-augmented pump therapy in type 1 diabetes: adolescents' and parents' search for harmony.
    Rashotte J; Tousignant K; Richardson C; Fothergill-Bourbonnais F; Nakhla MM; Olivier P; Lawson ML
    Can J Diabetes; 2014 Aug; 38(4):256-62. PubMed ID: 25023738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.
    Biester T; Nir J; Remus K; Farfel A; Muller I; Biester S; Atlas E; Dovc K; Bratina N; Kordonouri O; Battelino T; Philip M; Danne T; Nimri R
    Diabetes Obes Metab; 2019 Apr; 21(4):822-828. PubMed ID: 30478937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sources and Valence of Information Impacting Parents' Decisions to Use Diabetes Technologies in Young Children <8 Years Old with Type 1 Diabetes.
    Commissariat PV; Whitehouse AL; Hilliard ME; Miller KM; Harrington KR; Levy W; DeSalvo DJ; Van Name MA; Anderson BJ; Tamborlane WV; DiMeglio LA; Laffel LM
    Diabetes Technol Ther; 2020 Sep; 22(9):697-700. PubMed ID: 32077755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flash glucose monitoring in young people with type 1 diabetes-a qualitative study of young people, parents and health professionals: '
    Beasant L; Cullen F; Thomas E; Kandiyali R; Shield JPH; Mcgregor D; West N; Ingram J
    BMJ Open; 2023 Apr; 13(4):e070477. PubMed ID: 37076165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges of optimizing glycaemic control in children with Type 1 diabetes: a qualitative study of parents' experiences and views.
    Lawton J; Waugh N; Barnard KD; Noyes K; Harden J; Stephen J; McDowell J; Rankin D
    Diabet Med; 2015 Aug; 32(8):1063-70. PubMed ID: 25472898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting.
    Barnard KD; Wysocki T; Thabit H; Evans ML; Amiel S; Heller S; Young A; Hovorka R;
    Diabet Med; 2015 May; 32(5):601-8. PubMed ID: 25615888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Women's Experiences of Day-and-Night Closed-Loop Insulin Delivery During Type 1 Diabetes Pregnancy.
    Farrington C; Stewart Z; Hovorka R; Murphy H
    J Diabetes Sci Technol; 2018 Nov; 12(6):1125-1131. PubMed ID: 30288999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reexamining the Hypoglycemia Fear Survey for Parents of Young Children in a Sample of Children Using Insulin Pumps.
    Patton SR; Noser AE; Clements MA; Dolan LM; Powers SW
    Diabetes Technol Ther; 2017 Feb; 19(2):103-108. PubMed ID: 28118046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.